Atria Wealth Solutions’s Chemours CC Stock Holding History

Atria Wealth Solutions’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,033	Closed	-$253K	–	1665
2022 Q1	$253K	Buy	+8,033	New	+$251K	﹤0.01%	1416

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Atria Wealth Solutions's CC Position: Q2 2022 in Review

Atria Wealth Solutions sold out of Chemours (CC) in Q2 2022, closing a stake of 8,033 shares — an estimated $253K sold.

Atria Wealth Solutions first reported a position in CC in Q1 2022 and held it in 1 quarter. The position peaked at $253K in Q1 2022. 517 funds tracked by Wall St. Rank hold CC as of Q2 2022.

Atria Wealth Solutions reported no remaining Chemours position as of Q2 2022 after selling out during the quarter.
Atria Wealth Solutions sold 8,033 Chemours shares in Q2 2022, an estimated $253K.
Atria Wealth Solutions first reported a position in Chemours in Q1 2022 and held it in 1 quarter.
Atria Wealth Solutions's Chemours position peaked at $253K in Q1 2022.
517 funds tracked by Wall St. Rank held Chemours as of Q2 2022.

Based on Atria Wealth Solutions's 13F filing for Q2 2022, filed 15 Aug 2022.